Zi-Ran Li (Ziran Li)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Direct Oral Anticoagulants

Top Venues

Expert review of clinical pharmacology

Expert opinion on drug safety

Journal of clinical pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Qin Liu, Zi-Ran Li, Chen-Yu Wang, Zheng Jiao
Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing. Blood advances (2024)
Zhuo Wu, Zi-Ran Li, Xiaoyan Qiu, Mingkang Zhong, Tianling Ding
Germline genetic variations in methotrexate pathway are associated with pharmacokinetics, outcome, and toxicity in patients with primary central nervous system lymphoma. Expert review of clinical pharmacology (2023)
Zi-Ran Li, Chen-Yu Wang, Wei-Wei Lin, Yue-Ting Chen, Xiao-Qin Liu, Zheng Jiao
Handling Delayed or Missed Dose of Antiseizure Medications: A Model-Informed Individual Remedial Dosing. Neurology (2022)
Jun-Wei Chow, Ming-Ming Yan, Hui Zhao, Zi-Ran Li, Qian Zhang, Ming-Kang Zhong, Xiao-Yan Qiu
Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database. Expert opinion on drug safety (2022)
Wei-Wei Lin, Xiao-Qin Liu, Jia-Qin Gu, Zi-Ran Li, Zheng Jiao
How to handle a delayed or missed dose of edoxaban in patients with non-valvular atrial fibrillation? A model-informed remedial strategy. British journal of clinical pharmacology (2022)
Zi-Ran Li, Rui-Dong Li, Wan-Jie Niu, Xin-Yi Zheng, Zheng-Xin Wang, Ming-Kang Zhong, Xiao-Yan Qiu
Population Pharmacokinetic Modelling Combined with Machine Learning Approach Improved Tacrolimus Trough Concentrations Prediction in Chinese Adult Liver Transplant Recipients. Journal of clinical pharmacology (2022)
Yue-Ting Chen, Chen-Yu Wang, Yi-Wei Yin, Zi-Ran Li, Wei-Wei Lin, Min Zhu, Zheng Jiao
Population pharmacokinetics of oxcarbazepine: a systematic review. Expert review of clinical pharmacology 14 (7) (2021)
Ming-Ming Yan, Shu-Shan Wu, Yu-Peng Qi, Zi-Ran Li, Qian Zhang, Hui Zhao, Ming-Kang Zhong, Xiao-Yan Qiu
Association between cyclin-dependent kinase 4/6 inhibitors and venous thromboembolism: analysis of F.A.E.R.S. data. Expert opinion on drug safety (2021)
Xiao-Qin Liu, Wei-Wei Lin, Chen-Yu Wang, Zi-Ran Li, Xiao Zhu, Zheng Jiao
How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing. Expert review of clinical pharmacology 14 (9) (2021)